EudraCT Number: 2012-003012-31 Sponsor Protocol Number: 2011RC23r Start Date:
Sponsor Name: DIRECTION CENTRALE DU SERVICE DE SANTE DES ARMEES
Full Title: Cardiovascular effects of esmolol alone and in combination with levosimendan during septic shock
Medical condition:
Disease: Version SOC Term Classification Code Term Level
18.0 10021881 - Infections and infestations 10040070 Septic shock PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)

EudraCT Number: 2004-000290-58 Sponsor Protocol Number: SP755 Start Date:
Sponsor Name: SCHWARZ BIOSCIENCES GmbH
Full Title: Estudio multicéntrico, doble ciego, aleatorizado, controlado con placebo, en grupos paralelos, para investigar la eficacia y la seguridad de SPM927 (200 mg y 400 mg/día)como tratamiento complementa...
Medical condition: Partial seizures with or without secondary generalization
Disease: Version SOC Term Classification Code Term Level
Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: ES (Ongoing)
Trial results: View results
EudraCT Number: 2019-001399-13 Sponsor Protocol Number: 69HCL19_0115 Start Date:
Sponsor Name: Hospices Civils de Lyon
Full Title: MEK and Autophagy Inhibition in Metastatic/Locally Advanced, Unresectable NRAS Melanoma: A Phase Ib/II Trial of Trametinib plus Hydroxychloroquine in Patients with NRAS Melanoma. CHLORO TRAM MEL
Medical condition: Patients with metastatic NRAS melanoma
Disease: Version SOC Term Classification Code Term Level
20.0 100000004864 10027481 Metastatic melanoma LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)

EudraCT Number: 2007-002463-27 Sponsor Protocol Number: LY/AP-01/2007 Start Date:
Sponsor Name: Lybar a.s.
Full Title: Clinical study phase III evaluating the safety of Diffusil H Forte spray.
Medical condition: This is an open-label clinical study evaluating the safety of Diffusil H Forte spray in people with pediculosis or in increased risk of infection of pediculosis.
Disease: Version SOC Term Classification Code Term Level
9.1 10034208 Pediculosis LLT
Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: CZ (Completed)
Trial results: (No results available)
EudraCT Number: 2019-000845-12 Sponsor Protocol Number: 070219 Start Date:
Sponsor Name: Canisius Wilhelmina Ziekenhuis
Full Title: The effectiveness of vitamin D suppletion on improving symptoms of fatigue in children between 12 and 18 years old
Medical condition: Fatigue
Disease: Version SOC Term Classification Code Term Level
Population Age: Adolescents, Under 18 Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2008-003362-26 Sponsor Protocol Number: H552000-0809 Start Date:
Sponsor Name: Almirall Hermal GmbH
Full Title: A phase IIa single-center, randomized, controlled, observer-blind study to investigate the antimicrobial efficacy of topical formulations containing octenidine and prednicarbate in an"expanded flor...
Medical condition: Healthy volunteer trial to investigate whether topical formulations containing Octenidine and Octenidine plus Prednicarbate exert an in vivo antibacterial action on skin surface bacteria multiplied...
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results
EudraCT Number: 2005-000051-15 Sponsor Protocol Number: A4061008 Start Date:
Sponsor Name: Pfizer Pharma GmbH
Full Title: Continuing Access to the Tyrosine Kinase Inhibitor of VEGFR-2, AG-013736 (A406) for Patients Previously Receiving AG-013736 in Clinical Trials
Medical condition: Patients who have been treated in previous AG-013736 oncology studies
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed) CZ (Completed) IT (Completed) HU (Ongoing)
Trial results: (No results available)

EudraCT Number: 2010-018940-15 Sponsor Protocol Number: FLDX-001 Start Date:
Sponsor Name: SALUS Haus GmbH & Co. KG
Full Title: A Phase IV, multi-centre, randomized, open label study to investigate the efficacy and safety of Floradix® mit Eisen and ferro sanol® duodenal mite 50 mg in pregnant women with diagnosed iron defic...
Medical condition: Pregnant women with diagnosed iron deficiency
Disease: Version SOC Term Classification Code Term Level
12.1 10022976 Iron deficiency anemia secondary to inadequate dietary iron intake LLT
Population Age: Adults Gender: Female
Trial protocol: DE (Completed)
Trial results: (No results available)
EudraCT Number: 2020-003010-12 Sponsor Protocol Number: APHP180600 Start Date:
Sponsor Name: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
Full Title: «Efficacy of Fluticasone Propionate associated with Salmeterol using inhalation chamber versus placebo to improve the respiratory function in children over six years of age who underwent allogeneic...
Medical condition: Bronchiolitis Obliterative Syndrome after hematopoietic stem cell transplantation (HSCT). .
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)

EudraCT Number: 2018-004494-27 Sponsor Protocol Number: 5020DERM-2018 Start Date:
Sponsor Name: Landeskrankenhaus Salzburg
Full Title: pilotstudy- efficacy of infectoscab 5% creme in patients with scabies
Medical condition: Scabies
Disease: Version SOC Term Classification Code Term Level
20.1 10021881 - Infections and infestations 10039511 Scabies LLT
20.0 10021881 - Infections and infestations 10063409 Acarodermatitis PT
Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: AT (Ongoing)
Trial results: (No results available)